CareTrust REIT, Inc.
CTRE- Exchange
- NYSE
- Industry
- Real Estate Investment Trusts
- SEC CIK
- 0001590717
No open-market purchases or sales by CareTrust REIT, Inc. insiders were filed in the last 90 days; 521 institutions reported holding it in 13F filings for Q2 2026, worth $10.1B in total; Soros Fund Management is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:53 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 12, 2025 | Feb 8, 2024 | Feb 9, 2023 | Feb 16, 2022 |
| Revenue | $476.4M | $296.3M | $217.8M | $196.1M | $192.4M |
| Cost of revenue | – | – | – | – | $0 |
| Selling, general and administrative | $52.5M | $28.9M | $21.8M | $20.2M | $26.9M |
| Interest expense | $43.7M | $30.3M | $40.9M | $30.0M | $23.7M |
| Income tax | $5.00M | – | – | – | – |
| Net income | $320.5M | $125.1M | $53.7M | -$7.51M | $72.0M |
| EPS, basic | $1.57 | $0.81 | $0.50 | $-0.08 | $0.74 |
| EPS, diluted | $1.57 | $0.80 | $0.50 | $-0.08 | $0.74 |
| Weighted shares, basic | 203.6M | 154.8M | 106.0M | 96.7M | 96.0M |
| Weighted shares, diluted | 204.1M | 155.2M | 106.2M | 96.7M | 96.1M |
| Margins and growth | |||||
| Net margin | 67.3% | 42.2% | 24.7% | -3.8% | 37.4% |
| Revenue growth, year over year | +60.8% | +36.1% | +11.0% | +2.0% | +7.9% |
| Net income growth, year over year | +156.3% | +132.8% | – | −110.4% | −11.0% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 12, 2025 | Feb 8, 2024 | Feb 9, 2023 | Feb 16, 2022 |
| Cash and equivalents | $198.0M | $213.8M | $294.4M | $13.2M | $19.9M |
| Intangible assets | $48.8M | – | – | – | – |
| Total assets | $5.15B | $3.44B | $2.08B | $1.62B | $1.64B |
| Long-term debt | $894.2M | $396.9M | $595.6M | $719.5M | $673.4M |
| Total liabilities | $1.09B | $507.6M | $666.1M | $771.4M | $725.1M |
| Shareholders' equity | $4.04B | $2.91B | $1.42B | $849.4M | $915.8M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 12, 2025 | Feb 8, 2024 | Feb 9, 2023 | Feb 16, 2022 |
| Operating cash flow | $394.0M | $244.3M | $154.8M | $144.4M | $156.9M |
| Depreciation and amortization | $92.9M | $56.8M | $51.2M | $50.3M | $55.4M |
| Stock-based compensation | $11.9M | $6.13M | $5.15M | $5.76M | $10.8M |
| Dividends paid | $259.3M | $172.2M | $115.5M | $106.1M | $100.8M |
| Investing cash flow | -$1.46B | -$1.51B | -$267.8M | -$127.4M | -$192.6M |
| Financing cash flow | $1.05B | $1.19B | $394.3M | -$23.7M | $36.7M |
| Net change in cash | -$15.8M | -$80.6M | $281.3M | -$6.72M | $976.0K |
| Ratio | |||||
| Stock-based compensation, % of revenue | 2.5% | 2.1% | 2.4% | 2.9% | 5.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 4, 2026 | 257.7M | +15.4% | SEC |
| Aug 5, 2026 | 236.3M | +18.0% | SEC |
| May 6, 2026 | 236.2M | +23.2% | SEC |
| Feb 11, 2026 | 223.4M | +19.0% | SEC |
| Nov 4, 2025 | 223.3M | +30.2% | SEC |
| Aug 5, 2025 | 200.3M | +29.9% | SEC |
| Apr 30, 2025 | 191.7M | +34.9% | SEC |
| Feb 11, 2025 | 187.7M | +43.8% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.